Berkeley Lights, Inc. (BLI) Q3 2021 Earnings Call Transcript
BLI earnings call for the period ending September 30, 2021.
Source: fool.com
Page 8 - Berkeley Lights Platform News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Berkeley Lights Platform. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Berkeley Lights Platform Today - Breaking & Trending Today
Berkeley Lights, Inc: Berkeley Lights and Bayer announce a multi-year agreement aimed at revolutionizing the discovery of next-generation traits
Agreement debuts Berkeley Lights' rapid high-throughput functional screening capability to accelerate and expand the discovery and development of Bayer Crop Science's seeds and traits product pipelineEMERYVILLE
Source: finanznachrichten.de
Berkeley Lights, Inc: Berkeley Lights führt TechAccess Abonnements ein und nimmt erste Kunden unter Vertrag
EMERYVILLE, Kalifornien, June 04, 2021 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), ein führendes Unternehmen im Bereich der digitalen Zellbiologie, hat heute die Veröffentlichung seines TechAccess
Source: finanznachrichten.de
Berkeley Lights, Inc: Berkeley Lights releases subscription-based access program and signs first customers
EMERYVILLE, Calif., June 01, 2021 (GLOBE NEWSWIRE) -- Today, Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, announced the release of its TechAccess Subscription model to enable
Source: finanznachrichten.de
Investegate |Berkeley Lights, Inc Announcements | Berkeley Lights, Inc: Berkeley Lights Announces Opto™ Assure For Early Manufacturability Assessment of Antibody Therapeutics
Berkeley Lights Announces Opto™ Assure For Early Manufacturability Assessment of Antibody Therapeutics EMERYVILLE, Calif., April 05, 2021 (GLOBE NEWSWIRE) -- Today, Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, announced the launch of Opto Assure, a series of assays that provides yield and product quality data at an earlier stage in cell line development. The first of the series enables direct detection of product aggregates, ensuring a faster ramp toward volume production by evaluating biotherapeutic protein quality sooner in the antibody therapeutic development ...
Source: investegate.co.uk